PEPTIDE COMPLEXES
Geno-Wrinkle Pro™ combines six publicly listed peptides in a cosmetic concentrate for lines, texture and firmness formulation concepts. Use the blend as a starting point for a focused brief, with the target format, process and evidence plan defined before sample evaluation.
On this page Overview Composition Formulation Review Questions Enquire →
- Catalogue reference
- KI-047
- Product family
- Peptide complexes
- CAS reference
- Confirm for the exact supplied material
- Public INCI identity reference
- Request the complete declaration for the supplied product
The public overview identifies the catalogue material. Confirm the supplied grade, full composition and current batch specifications in the supplier documents.
Development directions
Lines & texture
Possible formulation formats
- Daily facial serum
- Night cream
- Targeted line-care concentrate
These are development concepts for discussion. Ingredient selection does not establish the performance or suitability of a finished product.
Publicly disclosed peptide composition
- Acetyl Hexapeptide-8
- Pentapeptide-18
- Dipeptide Diaminobutyroyl Benzylamide Diacetate
- Palmitoyl Pentapeptide-4
- Palmitoyl Tripeptide-1
- Palmitoyl Tetrapeptide-7
This active list is not the complete carrier, preservative or supplied-product INCI declaration. Request the full documentation for your material.
Published formulation information
| Parameter | Supplier-public reference |
|---|---|
| Supplied form / public description | Multi-peptide cosmetic active concentrate |
| Published use level | 1%–5% |
| Published addition stage | Below 40°C during cool-down |
| Public appearance description | Clear and homogeneous concentrate, as described in the stability FAQ |
| Public carrier description | Polyol-based micro-solubilization matrix |
Qualitative supplier description, not a published batch appearance acceptance specification.
The individual polyol/carrier INCI names and proportions are not stated.
Supplier-public descriptions are starting points. Confirm the current product documents and the percentage basis of any use-level guidance for your actual supplied material.
Formulation review priorities
| Review point | What to establish |
|---|---|
| Six peptides and the supplied matrix | Review all six named peptides together with the complete carrier and preservative system. Confirm active concentrations rather than treating blend percentage as peptide percentage. |
| Use level and processing | Public guidance gives a 1%-5% starting range and below-40°C cool-down addition. Confirm the percentage basis, mixing procedure and compatibility for the offered material. |
| pH and claim substantiation | A numerical formulation pH range is not established in the reviewed public material. Request current guidance and define formula-specific stability and performance testing. |
Public reference sources
Published supplier formulation reference →
Reference review: 18 October 2026. Public descriptions support identity and formulation discussions; confirm the documents for the exact offered material.
Questions for your brief
- Is the intended product a facial serum, night cream or targeted line-care format, and what appearance claim will you evaluate?
- What final pH, cool-down stage and other actives must the supplied concentrate fit?
- What use-level basis, full INCI declaration and sample quantity are required before the first prototype?
Can I use the 1%-5% range without knowing the concentrate composition?
Treat it as published starting guidance for a formulation discussion. Confirm the supplied-product composition and percentage basis before calculating active levels or comparing alternatives.
Which pH range should I use for development?
Request the current range for the offered concentrate. The reviewed public material does not establish a numerical formulation pH range; the product name and constituent peptides do not supply one.
Make your next enquiry specific.
Include the product identity, target market, formulation format, quantity and the documents needed for your review.